Uconceive, A First-of-Its-Kind Conception Kit Designed To Address Both Male And Female Fertility Issues, Awarded U.S. Patent For Safe, Effective Conception Support
Uconceive integrates techniques for predicting ovulation, confirming ovulation, fertility-enhancing nutraceuticals for both the male and female partners, and also a method for confirming a successful conception. In addition, Uconceive is the only product of its kind that specifically addresses the two phases of the female's ovulation cycle separately.
In fact, Uconceive is so special and uniquely different from all other products on the market that it has been awarded a United States patent.
Whether you're trying to conceive, wanting to time your pregnancy, or having difficulty conceiving – Uconceive can help. Older couples with a "ticking" biological clock will also benefit.
Make Uconceive your first option for conception. Uconceive – making families, one baby at a time.About the Uconceive development team: Dr. Scott Sweazy is a board-certified Urologist and Fertility Specialist. In his practice, he performs numerous fertility-enhancing surgical procedures and counsels couples regarding their conception options. Jill Sweazy has a PhD in health sciences and has worked in the pharmaceutical industry. She is the owner and President of Merriton Medical, LLC. For more information go to: www.Uconceive.com For media inquiries contact Sam Hare at:(803) 603-6763 Email This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com. SOURCE Uconceive
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV